V. Mendoza

Combined point of care SARS-CoV-2 nucleic acid and antibody testing in suspected moderate to severe COVID-19 disease

Steven F. Baker, Kenneth G. C. Smith, J. Briggs, 2020 .

Rapid point of care nucleic acid testing for SARS-CoV-2 in hospitalised patients: a clinical trial and implementation study

Kenneth G. C. Smith, G. Dougan, P. Lehner, 2020, medRxiv.

COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study

M. Parkes, C. Lees, T. Ahmad, 2022, The Lancet Gastroenterology & Hepatology.

COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study

M. Parkes, C. Lees, T. Ahmad, 2022, The Lancet Gastroenterology & Hepatology.

Brief Report Combined point of care SARS-CoV-2 nucleic acid and antibody testing in suspected moderate to severe COVID-19 disease.

Steven F. Baker, Nikos, Myra, 2020 .

Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant

Steven F. Baker, Kenneth G. C. Smith, N. Walker, 2020, Cell Reports Medicine.

Point of Care Nucleic Acid Testing for SARS-CoV-2 in Hospitalized Patients: A Clinical Validation Trial and Implementation Study

Kenneth G. C. Smith, G. Dougan, M. Weekes, 2020, Cell Reports Medicine.

Combined point of care nucleic acid and antibody testing for SARS-CoV-2: a prospective cohort study in suspected moderate to severe COVID-19 disease.

S. Baker, J. Briggs, A. Ritchie, 2020, medRxiv.